DMRA · Damora Therapeutics, Inc.
$29.00
-1.60 (-5.23%)
At close · Aug 28
Going-concern doubt
— flagged Aug 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“If we are unable to raise additional capital when needed, that could raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 10, 2026
Market Cap
$1.79B
Shares
61.74M
Damora Therapeutics, Inc. Earnings Call Transcripts
Quarterly earnings calls for Damora Therapeutics, Inc. (DMRA), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.
No Earnings Calls Available
No earnings call events are available for this stock yet.
Key facts
CIK
1800315
CUSIP
G2646Y104
13F (30d)
99 filings
99 filers
Visit website
Investor relations